Gene · 7913
Papers1,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Myoblast deactivation within engineered human skeletal muscle creates a transcriptionally heterogeneous population of quiescent satellite-like cells. | Biomaterials | 2022 | 35421801 | PubTator, text mining | PubMed |
| Dual Role of YY1 in HPV Life Cycle and Cervical Cancer Development. | Int J Mol Sci | 2022 | 35408813 | PubTator, text mining | PubMed |
| WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients. | J Clin Med | 2022 | 35407481 | PubTator, text mining | PubMed |
| Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear. | Head Neck Pathol | 2022 | 35397067 | PubTator, text mining | PubMed |
| Ogt Demonstrated Conspicuous Clinical Significance in Cancers, from Pan-Cancer to Small-Cell Lung Cancer. | J Oncol | 2022 | 35356257 | PubTator, text mining | PubMed |
| Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells. | Oncogene | 2022 | 35351996 | PubTator, text mining | PubMed |
| Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification. | Nat Commun | 2022 | 35347147 | PubTator, text mining | PubMed |
| Metachronous, non-pineal, trilateral retinoblastoma in a patient with a seemingly reduced-expressivity RB1 germline deletion. | Clin Case Rep | 2022 | 35340648 | PubTator, text mining | PubMed |
| Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities. | Cancers (Basel) | 2022 | 35326613 | PubTator, text mining | PubMed |
| Advances in High Throughput Proteomics Profiling in Establishing Potential Biomarkers for Gastrointestinal Cancer. | Cells | 2022 | 35326424 | PubTator, text mining | PubMed |
| pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation. | Stem Cells Transl Med | 2022 | 35325233 | PubTator, text mining | PubMed |
| OpenCell: Endogenous tagging for the cartography of human cellular organization. | Science | 2022 | 35271311 | PubTator, text mining | PubMed |
| Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy. | Int J Mol Sci | 2022 | 35269844 | PubTator, text mining | PubMed |
| Measurable Residual Disease in High-Risk Acute Myeloid Leukemia. | Cancers (Basel) | 2022 | 35267586 | PubTator, text mining | PubMed |
| Role of Biomarkers in FLT3 AML. | Cancers (Basel) | 2022 | 35267471 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| G3BP1 modulates SPOP to promote prostate tumorigenesis. | Mol Cell Oncol | 2022 | 35252555 | PubTator, text mining | PubMed |
| Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey. | Front Oncol | 2022 | 35251997 | PubTator, text mining | PubMed |
| Integrated Design of a Membrane-Lytic Peptide-Based Intravenous Nanotherapeutic Suppresses Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2022 | 35246961 | PubTator, text mining | PubMed |
| SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests. | Sci Rep | 2022 | 35233014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7913/papers?page=17